Cilostazol is a phosphodiesterase-3 (PDE3) inhibitor, used to treat intermittent claudication.
By inhibiting PDE3, it increases intracellular cyclic AMP (cAMP) levels, leading to vasodilation and platelet inhibition.
This effect improves blood flow to the extremities and reduces clotting risk.